Description:
Gain valuable insights into the evolving COVID-19 testing market with Kalorama Information’s comprehensive report, COVID-19 Testing Market Update, 2022. This report offers detailed market sizing and estimates for various COVID-19 tests and explores the market impacts of the ongoing pandemic. Throughout 2021 and into 2022, the relentless presence of COVID-19 has significantly influenced laboratories and in vitro diagnostic (IVD) companies, with testing expanding from large labs and clinics to home environments, boosting market revenues.
Diagnostics have been crucial in the response to COVID-19, underscoring the need for rapid and accurate testing to manage the pandemic effectively. The report anticipates continued investment in diagnostic systems, driven by the pandemic’s lessons and the importance of testing. The forecasted market analysis through 2027 considers demographic trends, new developments, the trajectory of COVID-19 and its variants, innovative technology, and global use.
Key Market Data:
- Test Types: The report breaks down market share by test type, including antigen, PCR, antibody, and point-of-care tests.
- Forecasts: While there is some uncertainty in exact forecasting, the report provides estimates and projections for the market through 2027.
Segmentation and Analysis: Our report includes comprehensive segmentation and breakout analysis, highlighting:
- Company Market Share: Competitive analysis of the top ten market participants.
- Trends and Innovations: Examination of market trends, products, and recent test innovations.
- Regional Breakdown: Detailed regional analysis covering North America, Europe, Asia-Pacific, and the Rest of the World.
Market Segmentation by Test Method:
- Immunoassay Antigen Tests: Used for identifying infected individuals and confirming safety for social interactions.
- Molecular PCR Tests: The most sensitive COVID-19 diagnostic tests, recommended by WHO for confirming diagnoses in symptomatic individuals.
- Immunoassay Antibody Tests: Provide information on individual protection through vaccination or previous infection.
For further details and to purchase directly, please contact us.
Sample Report: A sample is available as a PDF upon request.
Table: Global Lab-based COVID-19 Testing Market, Distribution of Sales by Segment, 2022-2027 (in millions $)
| Segment | Sales 2022 | % Mkt | Sales 2027 | % Mkt |
| Immunoassay | $XX Million | XX% | $XX Million | XX% |
| Molecular | $XX Million | XX% | $XX Million | XX% |
| Total, Lab-based COVID-19 Market | $XX Million | XX% | $XX Million | XX% |
Source: Kalorama Information
